NanoVibronix Cites Results From Independent Testing Of UroShield
Portfolio Pulse from Happy Mohamed
NanoVibronix, Inc. (NASDAQ:NAOV) has reported positive outcomes from a study of its UroShield device conducted at the University of Southampton. The study found that UroShield had a positive effect on catheter-associated urinary tract infections (CAUTI) and catheter blockage, with about one-third of patients citing a reduction in the frequency of catheter blockages. The device generates ultrasonic waves to prevent bacterial biofilm formation and may reduce the need for antibiotics.
August 30, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The positive study results for NanoVibronix's UroShield device could boost the company's reputation and increase demand for the product.
The positive study results indicate that the UroShield device is effective in reducing catheter-associated infections, which could lead to increased demand for the product and potentially boost NanoVibronix's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100